Atlas Trials

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Clinical trial NCT04358458 · TERMINATED

Trial details

NCT number
NCT04358458
Sponsor
Genmab
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone LymphomaSmall Lymphocytic LymphomaMantle Cell LymphomaChronic Lymphocytic LeukemiaHigh-grade B-cell LymphomaPrimary Mediastinal Large B-cell Lymphoma
Start date
2020-03-13
Primary completion
2022-11-21
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.